🔎 Trials Near Me

Dachaigh › Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil › Tennessee › Nashville

Sgrùdaidhean clionaigeach Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil ann an Nashville, TN

Tha 39 sgrùdaidhean airson Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil a’ lorg phàirtichean aig làraichean ann agus timcheall air Nashville (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

A’ fastadhÌre 1
  • Sarah Cannon Research Institute, Nashville
  • Tennessee Oncology PLLC, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06465069

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

A’ fastadhÌre 2/3
  • Site#0126, Nashville
  • Site #0116, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06788990

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

A’ fastadhÌre 1
  • Exelixis Clinical Site #3, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT05176483

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

A’ fastadhÌre 1
  • Sarah Cannon Research Institute - Pharmacy, Nashville
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07090499

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

A’ fastadhÌre 1
  • Research Site, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT05877599

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

A’ fastadhÌre 3
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07276399

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

A’ fastadhÌre 1/2
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06047379

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

A’ fastadhÌre 2
  • Vanderbilt University/Ingram Cancer Center, Nashville
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT04671667

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

A’ fastadhÌre 1
  • Sarah Cannon - Tennessee Oncology, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT05983432

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

A’ fastadhÌre 1/2
  • Sarah Cannon Research Institute, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT05267626

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

A’ fastadhÌre 1/2
  • Sarah Cannon Nashville, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07109726

A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC

A’ fastadhÌre 1
  • Sarah Cannon and HCA Research Institute, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT07462377

A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

A’ fastadhSgrùdadh amharc
  • Vanderbilt University, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06163534

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

A’ fastadhÌre 2
  • Vanderbilt-Ingram Cancer Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06769698

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

A’ fastadhÌre 1
  • Normunity Investigational Site, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07182149

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

A’ fastadhÌre 2/3
  • Vanderbilt University/Ingram Cancer Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT04333537

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT04895709

SMP-3124LP in Adults With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • SCRI Oncology Partners, Nashville
  • Vanderbilt-Ingram Cancer Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Lùna 2026 · NCT06526819

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

A’ fastadhÌre 1/2
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06330064

Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer

A’ fastadhÌre 1
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06819228

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

A’ fastadhÌre 1
  • Tennessee Oncology, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT06150664

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Sarah Cannon Research Institute, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT05768139

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

A’ fastadhÌre 1
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07460765

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

A’ fastadhÌre 1
  • US Oncology Research LLC, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT04389632

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

A’ fastadhÌre 1
  • SCRI Oncology Partners, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Ògmh 2026 · NCT07503808

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

A’ fastadhÌre 3
  • GSK Investigational Site, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Cèit 2026 · NCT06256588

Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma

A’ fastadhÌre 1
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT07217028

(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma

A’ fastadhÌre 1
  • Vanderbilt University/Ingram Cancer Center, Nashville
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 8 Cèit 2026 · NCT05747625

High-Resolution PET-CT Imaging for Surgical Margin Visualization

A’ fastadh
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Cèit 2026 · NCT06915454

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

A’ fastadh
  • Vanderbilt-Ingram Cancer Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT07555210

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • Tennessee Oncology, PLLC, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Gibl 2026 · NCT05785741

Evaluating 111In Panitumumab for Nodal Staging in Head and Neck Cancer

A’ fastadhÌre 1
  • Vanderbilt University/Ingram Cancer Center, Nashville
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 5 Màrt 2026 · NCT05901545

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

A’ fastadhÌre 1
  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Gearr 2026 · NCT06778863

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

A’ fastadhÌre 1/2
  • Research Site 136, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 21 Samh 2025 · NCT05914116

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • Vanderbilt-Ingram Cancer Center - Cool Springs, Nashville
  • Vanderbilt-Ingram Cancer Center at Franklin, Nashville
  • Veterans Affairs Medical Center - Nashville, Nashville
  • agus 1 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT00898638

Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer

A’ fastadhÌre 1
  • Vanderbilt University/Ingram Cancer Center, Nashville
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 3 Dàmh 2025 · NCT05945875

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Tennessee Oncology, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2025 · NCT05941507

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

A’ fastadhÌre 1
  • Vanderbilt University Medical Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Lùna 2025 · NCT04429542

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

A’ fastadhÌre 1 tràth
  • Vanderbilt University/Ingram Cancer Center, Nashville
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2024 · NCT05996432

Sgrùdaidhean Carcinoma Cealla Sgamach a' Chinn agus a' Mhuineil ann am bailtean eile

Sgrùdaidhean eile ann an Nashville

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.